Business
Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award.
About this update from Novaccess Global Inc.
[{"type":"text","content":"Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardCLEVELAND, OH / ACCESSWIRE / March 15, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, announced that Dr. Christopher Wheeler, Ph.D., President, StemVax Therapeutics Inc., a division of NovAccess Global and the lead scientist for the Company, received the prestigious Golden Axon Award at the World Brain Mapping Foundation (WBMF) Annual Congress, held on February 17, 2023, in Los Angeles, CA.The Golden Axon Award is presented to individuals connected with the medical community who inspire with goodwill and an enthusiastic interest in science, technology and medicine. Named for the neuron cell fiber that carries outgoing messages to other target cells, the founding principle of the Axon Award is to recognize a highly regarded individual in the public sector who helps raise awareness and funding of WBMF and its mission in the community via fundraising event(s) and activities. For additional information on the event and awards, please visit https://www.worldbrainmapping.org/Annual-Awards-Gala/.The World Brain Mapping Foundation's Annual Congress event -- "Gathering for Cure" Black Tie Gala -- is designed to recognize pioneers in brain mapping, health policy, neuroscience, and mental health philanthropy, amongst others, while connecting to its mission and bringing its message of neurotech innovation and innovation to the masses. The event also recognizes students, young investigators, and leaders in the field of brain mapping and therapeutics who have made significant contributions as trailblazers. Gala participants include major philanthropists, celebrities, NHL/NBA/MLS/NHF, leading scientists, physicians, neurosurgeons, and neurotechnology.At the annual congress, Dr. Wheeler and NovAccess CEO Dr. Dwain Irvin presented on immune targets and therapies for malignant brain tumors and disorders. This specifically impacts how NovAccess is currently developing vaccine immunotherapy for malignant brain tumors, as well as targets for its future improvement.About The World Brain Mapping Foundation and The Society for Brain Mapping and Therapeutics (SBMT)The World Brain Mapping Foundation focuses on helping wounded soldiers, brain and spine cancers, neurodegenerative diso...